Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 2Zollinger-Ellison Syndrome 1Thrombosis 1Thromboembolism 1Stomach Ulcer 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Polycythemia Vera 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Lymphoma, Follicular 1Ischemic Stroke 1Esophagitis, Peptic 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Dalteparin 4Saline Solution 3Gemcitabine 3Enoxaparin 3Warfarin 2Tinzaparin 2Heparin, Low-Molecular-Weight 2Fondaparinux 2Aspirin 2130-nm albumin-bound paclitaxel 2palbociclib 1isoquercitrin 1enoxaparin sodium 1edoxaban 1apixaban 1alvocidib 1Tranexamic Acid 1Sodium Chloride 1Sodium Bicarbonate 1Rivaroxaban 1Pentetic Acid 1PEGPH20 1Nadroparin 1Minocycline 1Ketoconazole 1Heparin 1Fluorodeoxyglucose F18 1Fluoridation 1Estramustine 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Thromboembolism × Clopidogrel × Clear all
NCT00020189 2013-06-19

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡